Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

A022

Sigma-Aldrich

1,3-Dipropyl-8-(p-sulfophenyl)xanthine

powder

Sign Into View Organizational & Contract Pricing

Select a Size

25 MG
$388.00

$388.00

Estimated to ship on18 May 2025

Request a Bulk Order
All Photos(1)

Select a Size

Change View
25 MG
$388.00

About This Item

Empirical Formula (Hill Notation):
C17H20N4O5S
CAS Number:
89073-57-4
Molecular Weight:
392.43
MDL number:
MFCD00055080
UNSPSC Code:
12352202
PubChem Substance ID:
24277726
NACRES:
NA.77

$388.00

Estimated to ship on18 May 2025

Request a Bulk Order

form

powder

Quality Level

100

color

white

solubility

DMSO: 5 mg/mL, clear

SMILES string

CCCN1C(=O)N(CCC)c2nc([nH]c2C1=O)-c3ccc(cc3)S(O)(=O)=O

InChI

1S/C17H20N4O5S/c1-3-9-20-15-13(16(22)21(10-4-2)17(20)23)18-14(19-15)11-5-7-12(8-6-11)27(24,25)26/h5-8H,3-4,9-10H2,1-2H3,(H,18,19)(H,24,25,26)

InChI key

IWALGNIFYOBRKC-UHFFFAOYSA-N

Gene Information

human ... ADORA1(134) , ADORA2B(136) , ADORA3(140)
rat ... Adora1(29290) , Adora2a(25369) , Adora3(25370)

Biochem/physiol Actions

Water soluble adenosine receptor antagonist with slight selectivity for A1 receptors.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
075K4707V
072M4752V
129K4732
075K4707
119H4703

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

M B Forman et al.
The Journal of pharmacology and experimental therapeutics, 292(3), 929-938 (2000-02-25)
Recent studies have demonstrated that three membrane-permeant A(1) receptor antagonists reduced infarct size in a model of ischemia followed by brief reperfusion. However, it was not determined whether cardioprotection was mediated by nonspecific intracellular effects of these highly lipophilic drugs
Serafim Guimarães et al.
Pharmacology & toxicology, 92(4), 160-162 (2003-05-20)
Chronic treatment of rats with 90 microg/kg/day DPSPX (1,3-dipropyl-8-sulphophenylxanthine) during seven days leads to a hypertensive state which is characterized by marked morphological changes of the blood vessel walls as well as by important functional alterations. While the angiotensin-converting enzyme
S P Tofovic et al.
Shock (Augusta, Ga.), 16(3), 196-202 (2001-09-04)
The purpose of this study was to investigate in vivo the effects of modulating the adenosine system on endotoxin-induced release of cytokines and changes in heart performance and neurohumoral status in early, profound endotoxemia in rats. Time/pressure variables of heart
R K Dubey et al.
Hypertension (Dallas, Tex. : 1979), 36(3), 337-342 (2000-09-16)
The extracellular "cAMP-adenosine pathway" refers to the local production of adenosine mediated by cAMP egress into the extracellular space, conversion of cAMP to AMP by ectophosphodiesterase, and the metabolism of AMP to adenosine by ecto-5'-nucleotidase. The goal of this study
Teresa Sousa et al.
European journal of pharmacology, 588(2-3), 267-276 (2008-06-04)
Treatment of Wistar rats for 7 days with 1,3-dipropyl-8-sulfophenylxanthine (DPSPX), an antagonist of adenosine receptors, induces long-lasting hypertension associated with marked changes in vascular structure and reactivity and renin-angiotensin system activation. This study aimed at evaluating the role of oxidative
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service